Overview

• Sanofi notified NaTHNaC on June 30 that UK supplies of the yellow fever vaccine Stamaril will be unavailable for two to three weeks, with new stocks not expected until mid-July.
• The Foreign Office’s Travel Health Pro guidance directs Yellow Fever Vaccination Centres to identify local alternative supplies and redirect travellers as needed.
• Travellers bound for high-risk regions in sub-Saharan Africa and Central and South America cannot receive the vaccine until stock is replenished.
• In the absence of immunization, individuals are urged to complete personal risk assessments and adopt strict mosquito-bite prevention measures, including long-sleeved clothing, DEET repellents and insecticide-treated nets.
• Health experts warn that yellow fever remains a potentially fatal disease and stress the importance of vaccination once supplies resume to secure lifelong protection.